术前贫血与慢性肢体威胁性缺血患者腹股沟下旁路术后不良结局相关
该研究基于NSQIP 2011-2014数据,纳入5081例因慢性肢体威胁性缺血(CLTI)行非急诊腹股沟下旁路术的患者,按术前血细胞比容(HCT)水平分层比较30天结局。多因素回归显示,重度贫血与死亡(OR 2.8,95%CI 1.3-6.3)、大截肢(OR 1.6,95%CI 1.01-2.6)及主要不良心血管事件(MACE)独立相关,且贫血与MACE的关联在术后输血患者中更强。
要点
- 重度贫血(HCT≤29%)患者死亡风险显著升高(OR 2.8,95%CI 1.3-6.3)。
- 重度贫血独立关联大截肢(OR 1.6,95%CI 1.01-2.6)与MACE(OR 1.9,95%CI 1.1-3.0)。
- 贫血与MACE的关联在术后输血患者中更强(交互P<.001),死亡无此差异。
核心结论
- CLTI患者腹股沟下旁路术后死亡及主要不良事件与术前HCT水平呈负相关,重度贫血者事件率最高。
- 贫血与MACE(而非死亡)的关联在术后输血患者中更强。
研究设计与样本
- 回顾性队列研究,利用NSQIP靶向血管模块2011-2014年数据,纳入5081例因CLTI行非急诊腹股沟下旁路术的患者。
- 按术前HCT分层:重度(≤29%)、中度(29.1%-34%)、轻度(34.1%-39%)、无贫血(>39%),以无贫血为参照。
- 采用多因素logistic回归分析贫血与术后30天结局的独立关联,并进行输血交互敏感性分析。
主要发现
- 贫血分布:重度741例(15%)、中度1317例(26%)、轻度1516例(30%)、无贫血1507例(30%)。
- 贫血患者年龄更大,组织缺损及合并症(高血压、糖尿病、肾功能不全)更常见(均P<.001)。
- 调整基线后,重度贫血死亡3.1%(OR 2.8,95%CI 1.3-6.3),中度贫血死亡3.0%(OR 2.6,95%CI 1.2-5.5),无贫血死亡0.7%。
- 重度贫血与大截肢独立相关(6.9% vs 3.3%;OR 1.6,95%CI 1.01-2.6)。
- 贫血与MACE相关:重度OR 1.9(95%CI 1.1-3.0),中度OR 1.9(95%CI 1.3-2.9),轻度OR 1.6(95%CI 1.1-2.4);与计划外重返手术室相关:重度OR 1.6(95%CI 1.2-2.1),中度OR 1.5(95%CI 1.2-1.8),轻度OR 1.3(95%CI 1.03-1.6)。
关键数值与推荐
- 贫血分层阈值:重度HCT≤29%,中度29.1%-34%,轻度34.1%-39%,无贫血>39%。
- 重度贫血死亡OR 2.8(95%CI 1.3-6.3),中度贫血死亡OR 2.6(95%CI 1.2-5.5),参照无贫血。
- 重度贫血大截肢OR 1.6(95%CI 1.01-2.6)。
- MACE的OR值:重度1.9(95%CI 1.1-3.0)、中度1.9(95%CI 1.3-2.9)、轻度1.6(95%CI 1.1-2.4)。
- 计划外重返手术室OR值:重度1.6(95%CI 1.2-2.1)、中度1.5(95%CI 1.2-1.8)、轻度1.3(95%CI 1.03-1.6)。
临床怎么用
- 对CLTI拟行腹股沟下旁路术的患者,术前应评估HCT水平,识别重度贫血高危人群。
- 重度贫血患者术后死亡、大截肢及MACE风险显著升高,需加强围手术期监测与管理。
- 术后输血与贫血的交互作用主要体现在MACE风险,提示输血决策需个体化权衡。
局限性
- 研究为回顾性队列分析,可能存在未测量的混杂因素。
- 仅纳入NSQIP数据库患者,结论外推需谨慎。
- 输血阈值未明确,需进一步研究确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Preoperative anemia in elderly patients undergoing surgery is prevalent and associated with adverse events; however, the interaction with other risk factors in patients with chronic limb-threatening ischemia (CLTI) is not well described. The purpose of this study was to assess the association between lower hematocrit (HCT) levels on admission and postoperative outcomes after infrainguinal bypass surgery. METHODS: Patients with CLTI undergoing nonemergent infrainguinal bypass were identified in the targeted vascular module of National Surgical Quality Improvement Program (NSQIP; 2011-2014). The 30-day outcomes were compared across preoperative HCT levels: severe (≤29%), moderate (29.1%-34%), mild (34.1%-39%), or no anemia (>39%), with no anemia serving as the reference group for all analyses. Independent associations between levels of anemia and postoperative outcomes were established using multivariable logistic regression. A sensitivity analysis was performed to assess interactions between preoperative anemia and blood transfusions. RESULTS: We identified 5081 patients undergoing bypass, of which 741 (15%) had severe, 1317 (26%) moderate, 1516 (30%) mild, and 1507 (30%) no anemia. Anemic patients were older and more commonly suffered from tissue loss and comorbidities (eg, hypertension, diabetes, and renal insufficiency; all P < .001). After adjustment for baseline conditions, mortality was higher in those with severe anemia (3.1%; odds ratio [OR], 2.8; 95% confidence interval [CI], 1.3-6.3) and moderate anemia (3.0%; OR, 2.6; 95% CI, 1.2-5.5) compared with those without anemia (0.7%). Severe anemia was independently associated with major amputation (6.9% vs 3.3%; OR, 1.6; 95% CI, 1.01-2.6) compared with no anemia. Anemia on admission was additionally associated with several other adverse outcomes, such as major adverse cardiovascular event (MACE; severe: OR, 1.9; 95% CI, 1.1-3.0; moderate: OR, 1.9; 95% CI, 1.3-2.9; mild: OR, 1.6; 95% CI, 1.1-2.4) and unplanned return to the operating room (severe: OR, 1.6; 95% CI, 1.2-2.1; moderate: OR, 1.5; 95% CI, 1.2-1.8; mild, OR: 1.3; 95% CI, 1.03-1.6). Moreover, mortality associated with preoperative anemia was not different in patients receiving postoperative blood transfusions compared with those who did not, whereas MACE was significantly higher in patients with preoperative anemia and blood transfusions (interaction; P < .001). CONCLUSIONS: Mortality and major adverse events in CLTI patients undergoing infrainguinal bypass are inversely associated with preoperative HCT levels, with the highest event rates in the most severely anemic patients. The correlation between anemia and MACE-but not mortality-was stronger in those patients receiving postoperative blood transfusions. Further research is needed to define an appropriate transfusion threshold, and attention should be focused on how to best optimize anemic CLTI patients before intervention.
引用
- Bodewes TCF, Pothof AB, Darling JD, et al. Preoperative anemia associated with adverse outcomes after infrainguinal bypass surgery in patients with chronic limb-threatening ischemia. J Vasc Surg. 2017. PMID: 28822661. doi:10.1016/j.jvs.2017.05.103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。